DRL enters branded consumer health arena through acquisition of six OTC brands

DRL will build upon the sales and marketing efforts for these brands and continue to focus on their expansion into existing and new market channels

Dr Reddy’s Laboratories (DRL) announced the acquisition of an eminent portfolio of over-the-counter (OTC) brands in the cough-and-cold, pain and dermatology categories. The company acquired six OTC brands from Ducere Pharma, including Doan’s, Bufferin, Nupercainal Ointment, Cruex Nail Gel, Comtrex and Myoflex.

According to Sonig, DRL will build upon the sales and marketing efforts for these brands and continue to focus on their expansion into existing and new market channels. Sonig commends the marketing and brand-building efforts of Ducere Pharma, recognising the organisation’s role in successfully revitalising the brands through improved distribution and promotional efforts.

Alok Sonig, Executive Vice President and Head of DRL’s in the US said, “We are entering the branded consumer health arena through these brands and embarking upon the next avenue of growth for our OTC business in the US.”